Brimonidine Tartrate CAS 70359-46-5 Assay 99.0%~101.0%
Shanghai Ruifu Chemical Co., Ltd. ke moetsi ea ka sehloohong oa Brimonidine Tartrate (CAS: 70359-46-5) e nang le boleng bo phahameng.Khetho ea α2-adrenergic receptor agonist, sethethefatsi se sebelisetsoang ho phekola glaucoma e bulehileng kapa khatello ea mali ea mahlo.Ruifu Chemical e ka fana ka lits'ebeletso tsa lefats'e ka bophara, theko ea tlholisano, litšebeletso tse ntle haholo, tse nyane le tse ngata tse fumanehang.Reka Brimonidine Tartrate,Please contact: alvin@ruifuchem.com
Lebitso la Lik'hemik'hale | "Brimonidine Tartrate" |
Litlhaloso tse tšoanang | Brimonidine L-Tartrate;UK 14304 Tartrate;AGN190342 Tartrate;5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-yl)quinoxalin-6-Amine Tartrate;5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-yl)-6-Quinoxalinamine Tartrate;5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-yl)quinoxalin-6-Amine (2R,3R) -2,3-Dihydroxysuccinate |
Boemo ba Setoko | Ka Stock, Tlhahiso ea Khoebo |
Nomoro ea CAS | 70359-46-5 |
Foromo ea limolek'hule | C11H10BrN5·C4H6O6 |
Boima ba Molek'hule | 442.23 g/mol |
Melting Point | 207.0~208.0℃(Dec.) |
E hloahloa | Ha e Mamelle Moeeng, Ha e Mamele Mocheso |
COA & MSDS | E fumaneha |
Tšimoloho | Shanghai, China |
Shelf Life | Likhoeli tse 24 Haeba li Behiloe Hantle |
Sehlopha | API (Active Pharmaceutical Angredient) |
Brand | Ruifu Chemical |
Lintho | Litlhaloso | Liphetho |
Ponahalo | E tšoeu kapa e mosehla hanyenyane kapa Phofo ea Brownish hanyenyane | E lumellana |
Boitsebiso A | Specific Optical Rotation | E lumellana |
Boitsebiso B | Spectrophotometry ea ho monya ha infrared | E lumellana |
Solubility | E qhibiliha ka metsing, hoo e batlang e sa qhibilihe ka har'a anhydrous ethanol le toluene | E lumellana |
Specific Optical Rotation | +9.0° ~ +10,5° | +9,6° |
Tahlehelo ka ho Omisa | ≤0.50% | 0.20% |
Molora o Sulfated | ≤0.20% | 0.07% |
Litšepe tse boima | ≤20ppm | <20ppm |
Lintho Tse Amanang | ||
Litšila tse boletsoeng | ||
N-(imidazolidin2ylidene)quinoxalin-6-amine | ≤0.10% | E lumellana |
5-bromoqulinoxalin-6-amine | ≤0.10% | E lumellana |
Quinoxalin-6-amine | ≤0.10% | E lumellana |
1-(5-bromoquinoxalin-6-yl)thiourea | ≤0.10% | E lumellana |
2-(5-bromoquinoxalin-6-yl)guanidine | ≤0.10% | E lumellana |
5-bromo-N-(1H-imidazol-2-yl)Quinoxalin-6-amine | ≤0.10% | E lumellana |
1-(2-aminoethyl)-3-(5-bromoquinoxalin-6-yl) urea | ≤0.10% | E lumellana |
Litšila tse sa Boleloeng | ≤0.10% | E lumellana |
Kakaretso | ≤0.20% | 0.12% |
Tlhahlobo | 99.0%~101.0%(ka Motheo o Omisitsoeng) | 99.8% |
Qetello | Sehlahisoa sena ka tlhahlobo se lumellana le BP2015 Standard |
Sephutheloana:Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka setshelo se kwetswe ka thata mme o se boloke sebakeng se phodileng, se omeletseng (2~8℃) le se nang le moya o hlwekileng hole le dintho tse sa dumellaneng.Qoba ho pepesehela letsatsi le tobileng, mongobo le mocheso o feteletseng.
Ho tsamaisa ka sekepe:Tsamaisa lefatšeng ka bophara ka sefofane, ka FedEx / DHL Express.Fana ka thomello e potlakileng le e tšepahalang.
Mokhoa oa ho Reka?Ka kopo ikopanyeDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Phihlelo ea Lilemo Tse 15?Re na le boiphihlelo ba lilemo tse fetang 15 ho etsa le ho romella kantle ho naha mefuta e mengata e fapaneng ea li-intermediate tsa boleng bo holimo tsa meriana kapa lik'hemik'hale tse ntle.
Limmaraka tse ka Sehloohong?Rekisetsa 'maraka oa lapeng, Amerika Leboea, Europe, India, Korea, Japane, Australia, joalo-joalo.
Melemo?Boleng bo phahameng, theko e theko e tlaase, lits'ebeletso tsa litsebi le ts'ehetso ea tekheniki, phano e potlakileng.
BolengTiisetso?Tsamaiso e thata ea taolo ea boleng.Lisebelisoa tsa profeshenale bakeng sa tlhahlobo li kenyelletsa NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, joalo-joalo.
Mehlala?Lihlahisoa tse ngata li fana ka mehlala ea mahala bakeng sa tlhahlobo ea boleng, litšenyehelo tsa ho tsamaisa thepa li lokela ho lefshoa ke bareki.
Feme Audit?Ho amoheloa ha fektheri.Ke kopa o etse kopano esale pele.
MOQ?Ha ho MOQ.Taelo e nyenyane e amoheleha.
Nako ea thomello? Haeba ka har'a setoko, ho netefalitsoe hore ho tsamaisoa ka matsatsi a mararo.
Lipalangoang?Ka Express (FedEx, DHL), ka Moea, ka Leoatle.
Litokomane?Ka mor'a tšebeletso ea thekiso: COA, MOA, ROS, MSDS, joalo-joalo e ka fanoa.
Custom Synthesis?E ka fana ka lits'ebeletso tsa tloaelo tsa ho kopanya ho lekana hantle litlhoko tsa hau tsa lipatlisiso.
Litefiso Melao?Invoice ea Proforma e tla romelloa pele kamora netefatso ea odara, e kenyellelitseng tlhahisoleseling ea rona ea banka.Tefo ka T/T (Telex Transfer), PayPal, Western Union, joalo-joalo.
Lipolelo tsa Kotsi H301: E chefo ha e koetsoe.
Lipolelo tsa Tlhokomelo
P501: Lahla likahare/ sets'oants'o setsing se lumelletsoeng sa ho lahlela litšila.
P270: U se ke ua ja, ua noa kapa ua tsuba ha u sebelisa sehlahisoa sena.
P264: Hlatsoa letlalo hantle ka mor'a ho tšoara.
P301 + P310 + P330: HA E MILE: Hang-hang bitsa POISON CENTER/ngaka.Hlatsoa molomo.
P405: Lebenkele le notletsoe.
Melao e Amanang:
Lintlha tsa Lipalangoang:
Nomoro ea UN (DOT-AIR) UN2811
Sehlopha (DOT-AIR) 6.1
Sehlopha sa ho Paka (TCI-A) III
HS Nomoro 2933.29.9000
Brimonidine Tartrate (CAS: 70359-46-5) ke khetho e phahameng ea α2-receptor blocker, e atlehileng ka katleho ke US Company Allergan, e leng meriana ea mahlo.E ka fokotsa khatello ea methapo ea methapo (IOP).Brimonidine Tartrate ophthalmic solution e rekisoang 'marakeng ke mofuta oa Brimonidine Tartrate, e leng moriana o motle oa ho theola IOP bakeng sa kalafo e sa foleng ea glaucoma ea mahlo le khatello ea mali ea mahlo ho bakuli, empa hape le maemong a argon laser IOP.Brimonidine Tartrate ophthalmic solution e na le mekhoa e 'meli ea ts'ebetso ka ho fokotsa tlhahiso ea metlae ea metsi le ho eketsa bokaholimo ba mokelikeli oa scleral outflow therapeutic.Ka mor'a ho oela ka leihlong, phello e potlakile, 'me e ka fihla tlhōrōng ha e sebelisoa ho fihlela ho 2h,' me nako e sebetsang e ka boloka 12h.Mali a khona ho bona mesaletsa ea lithethefatsi feela.Sehlahisoa sena se na le metabolism ea pele sebeteng, 'me metabolites e ntšoa ka har'a moroto ke liphio.Ho monya le ho ajoa ha systemic ha ho amehe, 'me batho ba tsofetseng ha ba hloke tokiso ea lethal dose.Brimonidine Tartrate ophthalmic solution ha e bapisoa le tse ling tsa α-blockers, mafura a qhibilihang ka mafura a nyane, athe ha ho bonolo ho feta mokoallong oa mali-boko 'me ha a hlahise sedation, hypotension le tse ling tse tšoanang le clonidine bohareng ba liketso tse mpe.Brimonidine Tartrate Ophthalmic Solution e khetha haholo bakeng sa li-receptor tsa α2-adrenergic, 'me karo-karolelano ea α2/α1 ea receptor affinity e feta makhetlo a 1000.Phello ea li-receptor tsa alpha 2 e ka lebisa khatellong e tlase ea intraocular.'Me karolo ea li-receptor tsa alpha 1 e ka lebisa ho fokotseheng ha methapo ea mali, ho theoha ha leihlo kapa ho fokotsa le ho atoloha ha seithuti.Tšebeliso ea nako e telele ea sehlahisoa sena e ke ke ea baka ho hloka kutlo ka potlako.Ntle le moo, ha e bapisoa le β-blockers, marotholi a mahlo a Brimonidine Tartrate bakeng sa litlamorao tse nyane tsa pelo, ha e na phello tšebetsong ea matšoafo, ka hona e loketse bakuli ba nang le bokooa β-blockers.Ho feta moo, ha e sebelisoa e le mong β-blocker, e ke ke ea finyella merero ea phekolo, 'me u ka eketsa FDA ka nako e le' ngoe.